Head of International Department
State Research Center − Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency is a lively platform for active international and interindustry cooperation. The Center conducts large-scale work within the framework of leading international organizations.
Among them the International Atomic Energy Agency https://www.iaea.org/ (IAEA), that is a global forum for scientific and technical cooperation in the peaceful uses of nuclear technology. The interaction covers such important areas as radiation safety and radiation monitoring, radiation protection of the population and territories, cancer treatment, training in the field of radiation diagnostics and therapy; providing emergency preparedness. The Center holds workshops on the site of the FMBA of Russia, organizes international internships of Russian specialists on this profile.
SRC-FMBC is a collaborating center of the World Health Organization http://www.who.int/ru/ (WHO) in the field of radiation medicine, namely, in the diagnosis and treatment of human radiation injuries. In addition, the specialists of the Center are permanent members of the WHO Scientific Advisory Committee of the International Electromagnetic Fields Project. By 2015 16 WHO CCs are successfully working in the world under the REMPAN program (the Radiation Emergency Medical Preparedness and Assistance Network), 4 of them in Russia. Undoubtedly, the leading positions, the largest experience and achievements in the field of treatment of patients with acute radiation injuries today belong to SRC-FMBC in Russia. The medical-radiological team of the WHO CC on a special-purpose radiation reconnaissance vehicle annually conducts mobile duty during major international events: Sochi Olympics 2014, 16th FINA World Championships in Kazan and others.
The Federal Medical Biophysical Center conducts an active scientific and practical work within the United Nations Scientific Committee on the Effects of Atomic Radiation http://www.unscear.org/ (UNSCEAR).
Traditionally, the positions of the specialists of the Center and the FMBA of Russia in the Russian representation among the members of the International Commission on Radiological Protection (ICRP), which develops scientific recommendations on the fundamental principles of radiation protection of personnel, the public and environmental protection, are strong. It should be emphasized that at annual meetings the ICRP members discuss, within five working days, the preparation of the most important documents being developed, which are later published in the form of ICRP recommendations. For Russia in general and for the FMBA of Russia in particular, it is important that the development of recommendations of the ICRP, which is the scientific basis for the further development of the IAEA safety standards, be conducted taking into account the experience of Russian scientists and with the participation of Russian specialists representing the FMBA of Russia.
The Russian Federation joined the International Radiation Protection Association http://www.irpa.net/ (IRPA) in 1972. Since the founding of the Russian branch of the IRPA to date, its permanent president is the Honorary President of State Research Center − Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, academician of the Russian Academy of Sciences Leonid Ilyin. Since December 18, 2009, the Scientific and Technical Council of the FMBA of Russia has been carrying out the authority of the Russian branch of IRPA, which up to this point has been assigned to the section "Radiation Hygiene" of the problem commission of the Russian Academy of Medical Sciences "Environmental Hygiene and Human Ecology". By now, the number of the Russian branch of IRPA has increased to 379 people, the absolute majority of whom are employees of SRC-FMBC.
Within the framework of interaction with the Norwegian Radiation Protection Authority http://www.nrpa.no/ (NRPA) State Research Center − Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency successfully implements contracts on a commercial basis. As a result of cooperation between the world's leading and Russian publications, more than 50 scientific papers have been published, 27 scientific and practical workshops in Russia and 15 workshops in Norway have been held. Projects for the development of software and mathematical systems for the 3-D visualization of the radiation situation are being implemented by the Center in cooperation with Institute for Energy Technology in Norway.
Russian-American cooperation to study the effects of radiation exposure is actively expanding. State Research Center − Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency acts as the coordinator of the work within the framework of the intergovernmental Agreement between the Government of the Russian Federation and the US Government on cooperation in studying radiation effects in order to minimize the impact of the effects of radioactive contamination on human health.
The launch of the Global Initiative to Combat Nuclear Terrorism (GICNT) was started on July 15, 2006 in St. Petersburg by a joint Russian-American statement by the Presidents of Russia and the United States. Employees of State Research Center − Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency take part in the events of the GICNT since 2015, as well as are a part of the Interdepartmental Commission.
The clinic of the Center conducts an intensive exchange of scientific and practical clinical developments in the field of nuclear medicine, transplantology, oncosurgery, molecular and cellular biology, in particular, in the use of stem cells for the treatment of patients.
Interaction and exchange of specialists with the University of Strasbourg http://en.unistra.fr/ (France), the University Hospital of Würzburg http://www.ukw.de/en/welcome-page.html (Germany), Mayo Clinic http://www.mayoclinic.org/ (USA) were established.
Clinicians of the Center are speakers and participants of important international forums, symposiums and conferences, where they share the results of ongoing clinical trials, sharing breakthrough technologies that move medical science forward.